These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34221846)

  • 1. Prediction and identification of T cell epitopes of COVID-19 with balanced cytokine response for the development of peptide based vaccines.
    Medha ; Bhatt P; Priyanka ; Sharma M; Sharma S
    In Silico Pharmacol; 2021; 9(1):40. PubMed ID: 34221846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a peptide-based vaccine from late stage specific immunogenic cross-reactive antigens of PE/PPE proteins of Mycobacterium tuberculosis.
    Medha ; Priyanka ; Sharma S; Sharma M
    Eur J Pharm Sci; 2022 Jan; 168():106051. PubMed ID: 34744006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2).
    Anand R; Biswal S; Bhatt R; Tiwary BN
    PeerJ; 2020; 8():e9855. PubMed ID: 33062414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
    Akhtar N; Joshi A; Singh B; Kaushik V
    Infect Disord Drug Targets; 2021; 21(4):541-552. PubMed ID: 32957905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A SARS-CoV-2 vaccine candidate:
    Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Saha RP; Lee SS; Chakraborty C
    Inform Med Unlocked; 2020; 20():100394. PubMed ID: 32835079
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Devi A; Chaitanya NSN
    J Biomol Struct Dyn; 2021 Nov; 39(18):6903-6917. PubMed ID: 32772892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain:
    Chukwudozie OS; Chukwuanukwu RC; Iroanya OO; Eze DM; Duru VC; Dele-Alimi TO; Kehinde BD; Bankole TT; Obi PC; Okinedo EU
    J Immunol Res; 2020; 2020():2837670. PubMed ID: 32964056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of conserved multi-epitopes based hybrid vaccine against SARS-CoV-2 variants: an immunoinformatic approach.
    Yaseen AR; Suleman M; Qadri AS; Asghar A; Arshad I; Khan DM
    In Silico Pharmacol; 2023; 11(1):18. PubMed ID: 37519944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach.
    Samad A; Ahammad F; Nain Z; Alam R; Imon RR; Hasan M; Rahman MS
    J Biomol Struct Dyn; 2022 Jan; 40(1):14-30. PubMed ID: 32677533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-informatics approach for multi-epitope vaccine designing against SARS-CoV-2.
    Banerjee S; Majumder K; Gutierrez GJ; Gupta D; Mittal B
    bioRxiv; 2020 Aug; ():. PubMed ID: 32743567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and validation of a multi-epitope in silico vaccine model for lymphatic filariasis by targeting
    Madanagopal P; Muthusamy S; Pradhan SN; Prince PR
    Bull Natl Res Cent; 2023; 47(1):47. PubMed ID: 36987521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2.
    Behmard E; Soleymani B; Najafi A; Barzegari E
    Sci Rep; 2020 Nov; 10(1):20864. PubMed ID: 33257716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis.
    Singh M; Bhatt P; Sharma M; Varma-Basil M; Chaudhry A; Sharma S
    Infect Genet Evol; 2019 Oct; 74():103930. PubMed ID: 31228643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches.
    Saha R; Ghosh P; Burra VLSP
    3 Biotech; 2021 Feb; 11(2):47. PubMed ID: 33457172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach.
    Bhatnager R; Bhasin M; Arora J; Dang AS
    J Biomol Struct Dyn; 2021 Sep; 39(15):5690-5705. PubMed ID: 32619134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82% global population coverage.
    Shukla P; Pandey P; Prasad B; Robinson T; Purohit R; D'Cruz LG; Tambuwala MM; Mutreja A; Harkin J; Rai TS; Murray EK; Gibson DS; Bjourson AJ
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34962259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational vaccinology guided design of multi-epitopes subunit vaccine designing against Hantaan virus and its validation through immune simulations.
    Ghafoor D; Kousar A; Ahmed W; Khan S; Ullah Z; Ullah N; Khan S; Ahmed S; Khan Z; Riaz R
    Infect Genet Evol; 2021 Sep; 93():104950. PubMed ID: 34089911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revolutionizing Nipah virus vaccinology: insights into subunit vaccine development strategies and immunological advances.
    Das T; Datta S; Sen A
    In Silico Pharmacol; 2024; 12(2):69. PubMed ID: 39070666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi Epitopic Peptide Based Vaccine Development Targeting Immobilization Antigen of
    Ghosh P; Patra P; Mondal N; Chini DS; Patra BC
    Int J Pept Res Ther; 2023; 29(1):11. PubMed ID: 36532362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.